Danier Moore, MD
Surgical Oncology · Washington, DCNPI 1316237282
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations.
Across 72 payments — averaging $26.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$290
- Novartis$204
- AstraZeneca$180
- Johnson & Johnson$158
- Axogen$155
- AbbVie$106
- plus $842 from 24 others
What the payments were for
- Food & beverage$1,936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 2 | $290 |
| Novartis | 4 | $204 |
| AstraZeneca(2 entities) | 10 | $180 |
| Johnson & Johnson | 7 | $158 |
| Axogen | 1 | $155 |
| AbbVie | 5 | $106 |
| Merck | 4 | $85 |
| Biocomposites Inc | 6 | $83 |
| Eisai Inc. | 4 | $72 |
| Exelixis Inc. | 3 | $63 |
| Incyte Corporation | 3 | $58 |
| Sobi, Inc | 1 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Bayer | 2 | $36 |
| Seagen Inc. | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Merit Medical Systems Inc | 1 | $30 |
| Impedimed, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Genmab U.S., Inc. | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $24 |
| Stemline Therapeutics Inc. | 1 | $23 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $18 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Acera Surgical, Inc. | 1 | $16 |
| Mindray DS USA, Inc. | 1 | $14 |
| Taiho Oncology, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Localizer$290
- AVANCE NERVE GRAFT$155
- AxoGuard Nerve Connector$155
- AxoGuard Nerve Protector$155
- AXOGUARD HA+ NERVE PROTECTOR$155
- AxoGuard Nerve Cap$155
- Trunode$148
- KISQALI$125
- PIQRAY$125
How this compares
Too few surgical oncology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 60 | $401 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Washington
- Wayne FrederickWashington$832K
- Mihir ShahWashington$84K
- Bonnie SunWashington$2K
- Robin WilliamsWashington$1K
- Waddah Al-RefaieWashington$1K
- Victor GallWashington$598
- Quyen ChuWashington$442
- Joyce WongWashington$315
- Jeffrey PeltonWashington$276
- Mark StevesWashington$219
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.